John A Glaspy (John Glaspy)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Endometrial Cancer

Peritoneal Dialysis

Top Venues

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Moshe Mittelman, David H Henry, John A Glaspy, Anil Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial. American journal of hematology (2024)
Moshe Mittelman, David H Henry, John A Glaspy, Anil Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial. American journal of hematology 99 (9) (2024)
Vina P Nguyen, Katie M Campbell, Theodore Scott Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga Carretero, Maggie L DiNome, Helena R Chang, Denise K Oseguera, Antoni Ribas, John A Glaspy
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer. Cancer research communications 3 (8) (2023)
John A Glaspy, Nashat Y Gabrail, Patricia Locantore-Ford, Tyson Lee, Katharina Modelska, Vivek Samal, David H Henry
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies. American journal of hematology (2023)
John A Glaspy, Nashat Y Gabrail, Patricia Locantore-Ford, Tyson Lee, Katharina Modelska, Vivek Samal, David H Henry
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies. American journal of hematology (2023)
Neil A O'Brien, Martina S J McDermott, Jun Zhang, Ke Wei Gong, Ming Lu, Benjamin Hoffstrom, Tong Luo, Raul Ayala, Kevin Chau, Min Liang, Athena M Madrid, Timothy R Donahue, John A Glaspy, Leonard Presta, Dennis J Slamon
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-drug Conjugate for Treatment of CLDN18.2 Positive Cancers. Molecular cancer therapeutics (2023)
Martina S J McDermott, Neil A O'Brien, Benjamin Hoffstrom, Ke Wei Gong, Ming Lu, Jun Zhang, Tong Luo, Min Liang, Weiping Jia, Jenny Hong, Kevin Chau, Simon Davenport, Bin Xie, Michael F Press, Richard Panayiotou, Abram Handly-Santana, Joan S Brugge, Leonard Presta, John A Glaspy, Dennis J Slamon
Preclinical Efficacy of the Antibody-Drug-Conjugate CLDN6-23-ADC for the Treatment of CLDN6 Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Zev A Wainberg, Arun S Singh, Gottfried E Konecny, Kelly E McCann, J Randolph Hecht, Jonathan Wade Goldman, Bartosz Chmielowski, Richard S Finn, Neil A O'Brien, Erika von Euw, Megan M Price, Diego Martinez, Lisa Yonemoto, Meghan Brennan, John A Glaspy, Dennis J Slamon
Preclinical and clinical trial results using Talazoparib and Low-Dose Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
David J Kuter, John A Glaspy, Robert T Means, Glenn M Chertow, Michael Auerbach
Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of internal medicine 175 (11) (2022)
Sara Alsterlind Hurvitz, Nicholas P McAndrew, Aditya Bardia, Michael F Press, Mark D Pegram, John P Crown, Peter Andreas Fasching, Bent Ejlertsen, Eric H Yang, John A Glaspy, Dennis J Slamon
A careful reassessment of anthracycline use in curable breast cancer. NPJ breast cancer 7 (1) (2021)
John A Glaspy, Myles Wolf, William E Strauss
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome. Advances in therapy 38 (7) (2021)
David H Henry, John A Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E Carraway, Charles Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin-Hung P Yu
Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study. American journal of hematology (2021)